| __timestamp | Amneal Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 23138050 |
| Thursday, January 1, 2015 | 136870000 | 57410147 |
| Friday, January 1, 2016 | 204747000 | 41454452 |
| Sunday, January 1, 2017 | 191938000 | 31690298 |
| Monday, January 1, 2018 | 210451000 | 52968505 |
| Tuesday, January 1, 2019 | 202287000 | 81048686 |
| Wednesday, January 1, 2020 | 190585000 | 128874979 |
| Friday, January 1, 2021 | 209563000 | 206342000 |
| Saturday, January 1, 2022 | 200046000 | 297307000 |
| Sunday, January 1, 2023 | 167778000 | 353188000 |
| Monday, January 1, 2024 | 505870000 |
Data in motion
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Amneal Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their R&D investments. From 2014 to 2023, Amneal's R&D expenses have shown a steady pattern, peaking in 2018 with a 97% increase from 2014, before tapering off in recent years. In contrast, Arrowhead has exhibited a remarkable upward trend, with R&D expenses surging by over 1,400% from 2014 to 2023. This stark difference highlights Arrowhead's aggressive push towards innovation, particularly in the last five years, where their R&D spending has consistently outpaced Amneal's. As we look to the future, the absence of data for Amneal in 2024 raises questions about their strategic direction, while Arrowhead's continued investment suggests a commitment to pioneering new therapies.
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Merck & Co., Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
R&D Spending Showdown: Incyte Corporation vs Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Comparing Innovation Spending: Amneal Pharmaceuticals, Inc. and Xencor, Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Arrowhead Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Geron Corporation
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.